Health Care & Life Sciences » Biotechnology | Bioblast Pharma Ltd.

Bioblast Pharma Ltd. | Ownership

Companies that own Bioblast Pharma Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Renaissance Technologies LLC
100,760
3.02%
4,100
0%
06/30/2018
Yelin Lapidot Mutual Fund Management Ltd.
58,440
1.75%
0
0.01%
06/28/2018
UBS Securities LLC
2,224
0.07%
-93
0%
06/30/2018
Securities America Advisors, Inc.
200
0.01%
0
0%
06/30/2018
G1 Execution Services LLC
0
0%
-19,212
0%
06/30/2018

About Bioblast Pharma

View Profile
Address
37 Dereh Menachem Begin Street
Tel Aviv TA 6522042
Israel
Employees -
Website http://www.bioblastpharma.com
Updated 09/14/2018
Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment.